Intellia Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Intellia Therapeutics Inc
CIK #0001652130
EDGAR Form CIK 2011 - 2026
10-K [0001652130]
10-Q [0001652130]
3 [0001652130]
4 [0001652130]
5 [0001652130]
8-K [0001652130]
D [0001652130]
SC 13D [0001652130]
SC 13G [0001652130]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Capital Management LLC Intellia Therapeutics Inc [2026-04-30]
Vanguard Portfolio Management LLC Intellia Therapeutics Inc [2026-04-29]
State Street Corp Intellia Therapeutics Inc [2026-02-09]
Goldman Sachs Group Inc Intellia Therapeutics Inc [2025-11-12]
Contrarius Investment Management Ltd Intellia Therapeutics Inc [2025-11-12]
State Street Corp Intellia Therapeutics Inc [2025-05-13]
BlackRock Inc Intellia Therapeutics Inc [2023-01-25]
FMR LLC Intellia Therapeutics Inc [2022-02-09]
Sumitomo Mitsui Trust Holdings Inc Intellia Therapeutics Inc [2019-07-09]
Nikko Asset Management Americas Inc Intellia Therapeutics Inc [2019-07-09]
View All
Form 3/4/5 Subject 2011 - 2026
Intellia Therapeutics Inc
Dulac Edward J III
Dube Michael P
Bhanji Muna
Goodman Jesse
Cohen Fred E
Goff Brian
Keresty Georgia
Verwiel Frank
Chase William J
Schultes Birgit C
Lebwohl David
Basta James
Leonard John M
Clark Eliana
Sepp-Lorenzino Laura
Hicks Derek
Goddard Glenn
Crowley John F
Dorsa Caroline
Formela Jean Francois
Rivera Jose E
Schiermeier Andrew
Karsen Perry A
Novartis AG
Novartis Institutes for BioMedical Research Inc
Hayes John T
Bell Graeme
Caribou Biosciences Inc
Bermingham Nessan
Slaoui Moncef
Atlas Venture Fund IX LP
Atlas Venture Associates IX LP
Atlas Venture Associates IX LLC
Gordon Carl L
Morrissey David V
Heifner Nicole
Barnes Thomas M
OrbiMed Capital GP V LLC
OrbiMed Global Healthcare GP LLC
Isaly Samuel D
OrbiMed Advisors LLC
TLS Beta Pte Ltd
Temasek Life Sciences Private Ltd
Fullerton Management Pte Ltd
Temasek Holdings Private Ltd
Haurwitz Rachel E
Caribou Therapeutics HoldCo LLC
Baker Bros Advisors GP LLC
Baker Julian
Baker Felix
Baker Bros Advisors LP
Srivastava Sapna
Tananbaum James B
Foresite Capital Fund III LP
Foresite Capital Management III LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Intellia Therapeutics Inc NTLA
Common Stock
2026-03-02 Sell 607 $13.78 8,364
Intellia Therapeutics Inc NTLA
Common Stock
2026-03-02 Sell 1,211 $13.78 16,688
Intellia Therapeutics Inc NTLA
Common Stock
2026-03-01 Grant 17,250 $0.00
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
2026-03-01 Grant 10,505 $0.00
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
2026-03-01 Grant 56,000 $0.00
Intellia Therapeutics Inc NTLA
Common Stock
2026-03-01 Grant 9,943 $0.00
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
2026-03-01 Grant 14,204 $0.00
Intellia Therapeutics Inc NTLA
Common Stock
2026-03-01 Grant 156,400 $0.00
Intellia Therapeutics Inc NTLA
Common Stock
2026-03-01 Grant 61,280 $0.00
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
2026-03-01 Grant 65,829 $0.00
Intellia Therapeutics Inc NTLA
Common Stock
2026-03-01 Grant 46,080 $0.00
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
2026-03-01 Grant 87,543 $0.00
Intellia Therapeutics Inc NTLA
Common Stock
2026-03-01 Grant 7,353 $0.00
Intellia Therapeutics Inc NTLA
Common Stock
2026-03-01 Grant 39,200 $0.00
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
2026-03-01 Grant 225,400 $0.00
Intellia Therapeutics Inc NTLA
Common Stock
2026-01-05 Sell 34,146 $9.21 314,485
Intellia Therapeutics Inc NTLA
Common Stock
2026-01-05 Buy 150,000 $9.35 1,402,500
Intellia Therapeutics Inc NTLA
Common Stock
2026-01-05 Sell 9,515 $9.21 87,633
Intellia Therapeutics Inc NTLA
Common Stock
2026-01-05 Sell 10,397 $9.21 95,756
Intellia Therapeutics Inc NTLA
Common Stock
2026-01-05 Sell 2,989 $9.21 27,529
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com